[144] CME Group Inc. SEC Filing
CME Group Inc. (CME) Form 144 notice reports a proposed sale of 32,468 shares of Common stock through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $200,054.83 and approximate sale date of 08/18/2025. The shares were acquired as restricted stock from the issuer on 05/02/2024 and were fully paid on that date. The filing lists 360,377,042 shares outstanding. Certain fields such as the identity or relationship of the selling person and the filing contact details are not populated in the provided text. The filer represents they are not aware of undisclosed material adverse information and affirms the signature and certification language required by Form 144.
CME Group Inc. (CME) ha presentato un avviso Form 144 per la proposta vendita di 32.468 azioni ordinarie tramite Morgan Stanley Smith Barney LLC su NASDAQ, con un valore di mercato complessivo di $200.054,83 e una data di vendita approssimativa del 18/08/2025. Le azioni erano state acquisite come restricted stock dall'emittente il 02/05/2024 e risultavano integralmente pagate in quella data. Il documento riporta 360.377.042 azioni in circolazione. Alcuni campi, come l'identità o il rapporto del venditore e i contatti del deposito, non sono compilati nel testo fornito. Il dichiarante afferma di non essere a conoscenza di informazioni materialmente avverse non divulgate e conferma la firma e le dichiarazioni di certificazione richieste dal Form 144.
CME Group Inc. (CME) presentó un aviso Form 144 que informa sobre una propuesta de venta de 32.468 acciones ordinarias a través de Morgan Stanley Smith Barney LLC en NASDAQ, con un valor de mercado agregado de $200.054,83 y una fecha de venta aproximada del 18/08/2025. Las acciones se adquirieron como restricted stock del emisor el 02/05/2024 y fueron pagadas en su totalidad en esa fecha. La presentación indica 360.377.042 acciones en circulación. Algunos campos, como la identidad o la relación de la persona vendedora y los datos de contacto del presentador, no aparecen completados en el texto proporcionado. El declarante afirma no tener conocimiento de información material adversa no divulgada y ratifica la firma y el lenguaje de certificación exigidos por el Form 144.
CME Group Inc. (CME)는 Morgan Stanley Smith Barney LLC를 통해 NASDAQ에서 보통주 32,468주를 매도할 예정임을 알리는 Form 144 공지를 제출했으며, 총 시가총액 $200,054.83, 예상 매도일 2025-08-18로 기재되어 있습니다. 해당 주식은 발행인으로부터 2024-05-02에 restricted stock으로 취득되었고 그날 완납되었습니다. 제출서류에는 360,377,042주의 발행주식수가 기재되어 있습니다. 판매자 신원이나 관계, 제출 담당자 연락처 등 일부 항목은 제공된 텍스트에 기재되지 않았습니다. 제출인은 공개되지 않은 중요 불리한 정보가 없음을 진술하고 Form 144에 요구되는 서명 및 인증 문구를 확인합니다.
CME Group Inc. (CME) a déposé un avis Form 144 signalant une proposition de vente de 32 468 actions ordinaires via Morgan Stanley Smith Barney LLC sur le NASDAQ, pour une valeur de marché totale de 200 054,83 $ et une date de vente approximative au 18/08/2025. Les actions ont été acquises en tant que restricted stock de l'émetteur le 02/05/2024 et ont été intégralement payées à cette date. Le dépôt indique 360 377 042 actions en circulation. Certains champs, tels que l'identité ou la relation de la personne vendeuse et les coordonnées du déclarant, ne sont pas renseignés dans le texte fourni. Le déclarant affirme ne pas avoir connaissance d'informations défavorables importantes non divulguées et confirme la signature ainsi que la clause de certification exigées par le Form 144.
CME Group Inc. (CME) hat eine Form-144-Meldung eingereicht, die den geplanten Verkauf von 32.468 Stammaktien über Morgan Stanley Smith Barney LLC an der NASDAQ meldet, mit einem gesamten Marktwert von $200.054,83 und einem circa-Verkaufsdatum am 18.08.2025. Die Aktien wurden am 02.05.2024 als restricted stock vom Emittenten erworben und an diesem Datum vollständig bezahlt. In der Einreichung werden 360.377.042 ausstehende Aktien angegeben. Bestimmte Felder, wie die Identität oder das Verhältnis der verkaufenden Person sowie die Kontaktdaten des Einreichers, sind im vorliegenden Text nicht ausgefüllt. Der Einreicher erklärt, dass ihm keine nicht offengelegten, wesentlichen nachteiligen Informationen bekannt sind, und bestätigt die für Form 144 erforderliche Unterschrifts- und Zertifizierungserklärung.
- Transaction details provided: class, broker, share count, market value, acquisition date, and sale date are all stated
- Acquisition basis disclosed: shares were acquired as restricted stock from the issuer on 05/02/2024
- Form 144 certifications included: seller represents no undisclosed material adverse information and includes required signature language
- None.
Insights
TL;DR: Routine Rule 144 sale notice for restricted shares; transaction size and timing are clearly stated without material corporate developments.
The filing documents a proposed sale of 32,468 restricted shares acquired from the issuer on 05/02/2024, with an aggregate market value of $200,054.83 and an anticipated sale date of 08/18/2025 via Morgan Stanley Smith Barney LLC on NASDAQ. The notice contains standard certifications required under Rule 144 but does not provide the seller's relationship to the issuer or contact details in the excerpt provided. For investors, this appears to be a compliance filing to register an intended sale rather than disclosure of operational or financial developments.
TL;DR: Form 144 appears completed for a restricted-stock disposition; required seller representations are present though some identifying fields are blank.
The notice includes required transaction details: class of security, broker name, number of shares, market value, outstanding shares, acquisition date and nature (restricted stock), and payment information. The certification language affirming lack of undisclosed material adverse information and warning about false statements is included. Missing or blank fields in the provided excerpt—such as filer contact information and the seller's stated relationship to the issuer—should be confirmed in the full filing record to ensure regulatory completeness.
CME Group Inc. (CME) ha presentato un avviso Form 144 per la proposta vendita di 32.468 azioni ordinarie tramite Morgan Stanley Smith Barney LLC su NASDAQ, con un valore di mercato complessivo di $200.054,83 e una data di vendita approssimativa del 18/08/2025. Le azioni erano state acquisite come restricted stock dall'emittente il 02/05/2024 e risultavano integralmente pagate in quella data. Il documento riporta 360.377.042 azioni in circolazione. Alcuni campi, come l'identità o il rapporto del venditore e i contatti del deposito, non sono compilati nel testo fornito. Il dichiarante afferma di non essere a conoscenza di informazioni materialmente avverse non divulgate e conferma la firma e le dichiarazioni di certificazione richieste dal Form 144.
CME Group Inc. (CME) presentó un aviso Form 144 que informa sobre una propuesta de venta de 32.468 acciones ordinarias a través de Morgan Stanley Smith Barney LLC en NASDAQ, con un valor de mercado agregado de $200.054,83 y una fecha de venta aproximada del 18/08/2025. Las acciones se adquirieron como restricted stock del emisor el 02/05/2024 y fueron pagadas en su totalidad en esa fecha. La presentación indica 360.377.042 acciones en circulación. Algunos campos, como la identidad o la relación de la persona vendedora y los datos de contacto del presentador, no aparecen completados en el texto proporcionado. El declarante afirma no tener conocimiento de información material adversa no divulgada y ratifica la firma y el lenguaje de certificación exigidos por el Form 144.
CME Group Inc. (CME)는 Morgan Stanley Smith Barney LLC를 통해 NASDAQ에서 보통주 32,468주를 매도할 예정임을 알리는 Form 144 공지를 제출했으며, 총 시가총액 $200,054.83, 예상 매도일 2025-08-18로 기재되어 있습니다. 해당 주식은 발행인으로부터 2024-05-02에 restricted stock으로 취득되었고 그날 완납되었습니다. 제출서류에는 360,377,042주의 발행주식수가 기재되어 있습니다. 판매자 신원이나 관계, 제출 담당자 연락처 등 일부 항목은 제공된 텍스트에 기재되지 않았습니다. 제출인은 공개되지 않은 중요 불리한 정보가 없음을 진술하고 Form 144에 요구되는 서명 및 인증 문구를 확인합니다.
CME Group Inc. (CME) a déposé un avis Form 144 signalant une proposition de vente de 32 468 actions ordinaires via Morgan Stanley Smith Barney LLC sur le NASDAQ, pour une valeur de marché totale de 200 054,83 $ et une date de vente approximative au 18/08/2025. Les actions ont été acquises en tant que restricted stock de l'émetteur le 02/05/2024 et ont été intégralement payées à cette date. Le dépôt indique 360 377 042 actions en circulation. Certains champs, tels que l'identité ou la relation de la personne vendeuse et les coordonnées du déclarant, ne sont pas renseignés dans le texte fourni. Le déclarant affirme ne pas avoir connaissance d'informations défavorables importantes non divulguées et confirme la signature ainsi que la clause de certification exigées par le Form 144.
CME Group Inc. (CME) hat eine Form-144-Meldung eingereicht, die den geplanten Verkauf von 32.468 Stammaktien über Morgan Stanley Smith Barney LLC an der NASDAQ meldet, mit einem gesamten Marktwert von $200.054,83 und einem circa-Verkaufsdatum am 18.08.2025. Die Aktien wurden am 02.05.2024 als restricted stock vom Emittenten erworben und an diesem Datum vollständig bezahlt. In der Einreichung werden 360.377.042 ausstehende Aktien angegeben. Bestimmte Felder, wie die Identität oder das Verhältnis der verkaufenden Person sowie die Kontaktdaten des Einreichers, sind im vorliegenden Text nicht ausgefüllt. Der Einreicher erklärt, dass ihm keine nicht offengelegten, wesentlichen nachteiligen Informationen bekannt sind, und bestätigt die für Form 144 erforderliche Unterschrifts- und Zertifizierungserklärung.
FAQ
What does the CME Form 144 filing disclose about the proposed sale?
When and how were the securities being sold acquired according to the filing?
How many shares of CME are reported outstanding in this notice?
Does the Form 144 filing state the seller's relationship to CME?
Which broker is handling the proposed sale in the Form 144?
